Biology subjects

Sieber, P.

Publications and source records attributed to Sieber, P..

3 recordsLinked to original sources

bioRxiv2025

Spatial Biodiversity Indicators and a Composite Index for Conservation Prioritization in Switzerland

Spatially explicit indicators that quantify to which extent landscapes support biodiversity are essential for guiding evidence-based conservation planning. Here, we present a 25-meter resolution dataset for Switzerland, encompassing three key biodiversity indicators-- Complementarity, Extinction Risk, and Ecological Connectivity--developed across 17 major taxonomic groups, using habitat suitability maps for approximately 7,500 individual species. These three indicators capture (1) the contribution of landscapes to taxonomic, functional, and phylogenetic diversity, (2) species vulnerability to extinction and (3) ecological connectivity. Outputs are provided for both terrestrial and aquatic realms, including versions adjusted for species richness, and integrated into composite indices. In total, 272 spatial layers were produced and made openly accessible. Relationships among the three indicators were analyzed to assess their distinct contributions, and expert-based validations were performed to evaluate their ecological plausibility and relevance for conservation applications. This dataset provides a robust foundation to support spatial planning and conservation decision-making in Switzerland and can be used as a blueprint for analogue integration in other countries.

ecology↗

bioRxiv2024

Targeting the expansion of myeloid-derived suppressor cells in liver cirrhosis

Background and aimsPreviously, we identified immune-suppressive circulating monocytic myeloid-derived suppressor cells (M-MDSC) in patients with cirrhosis and liver failure, which increased with disease severity and were associated with infections and mortality. Impaired immune responses and M-MDSC expansion were reversed by ex vivo polyinosinic:polycytidylic acid (poly(I:C)) treatment. Here, we aimed to investigate hepatic MDSC subsets in liver biopsies of cirrhotic patients and identify MDSC subsets in murine models to assess the safety and efficacy of poly(I:C) in vivo. Methods22 cirrhotic patients and 4 controls were clinically characterised. MDSC were identified in liver biopsies (immunofluorescence) and in the circulation (flow cytometry). M- MDSC phenotype and function following poly(I:C) stimulation were assessed ex vivo. Carbon tetrachloride-based murine models of liver fibrosis were used. Poly(I:C) was administered therapeutically. MDSC biology was investigated with flow cytometry, immunofluorescence and T-cell proliferation assay. Hepatic histopathology, transcriptomics (BulkRNAseq) and serum markers were assessed. ResultsBesides circulating M-MDSC, hepatic CD14+CD84+M-MDSC and CD15+CD84+ polymorphonuclear-MDSC expanded in cirrhotic patients and indicated disease severity, infections and poor survival. Poly(I:C) treatment reversed phenotype and function of circulating M-MDSC ex vivo. Circulating and hepatic MDSC expanded in our murine models of liver fibrosis and suppressed T-cell proliferation. Lipopolysaccharide and E.coli challenge exacerbated hepatic MDSC and fibrosis compared to CCl4 controls. Poly(I:C) therapy reduced MDSC expansion in fibrotic mice with bacterial infection and CCl4-induced fibrosis. ConclusionHepatic MDSC expanded in cirrhotic patients and were linked with disease severity and poor prognosis. Poly(I:C) reversed frequency and function of M-MDSC ex vivo. Poly(I:C) therapy reversed MDSC expansion and fibrosis in a murine model of liver fibrosis with infection. Thus, we highlighted poly(I:C) as a potential immunotherapy for the treatment of immuneparesis in cirrhosis.

immunology↗

bioRxiv2019

The landscape of the alternatively spliced transcriptome remains stable during aging across different species and tissues

Aging is characterized by a decline of cellular homeostasis over time, leading to various severe disorders and death. Alternative splicing is an important regulatory level of gene expression and thus takes on a key role in the maintenance of accurate cell and tissue function. Missplicing of certain genes has already been linked to several age-associated diseases, such as progeria, Alzheimers disease, Parkinsons disease and cancer. Nevertheless, many studies focus only on transcriptional variations of single genes or the expression changes of spliceosomal genes, coding for the proteins that aggregate to the spliceosomal machinery. Little is known on the general change of present and switching isoforms in different tissues over time. In this descriptive RNA-Seq study, we report differences and commonalities of isoform usage during aging among different tissues within one species and compare changes of alternative splicing among different, evolutionarily distinct species. Although we identified a multitude of differntially spliced genes among different time points, we observed little to no general changes in the transcriptomic landscape of the investigated samples. Although there is undoubtedly considerable influence of specifically spliced genes on certain age-associated processes, this work shows that alternative splicing remains stable for the majority of genes with aging.

bioinformatics↗